MedRegWatch

← Alert archive

Class 2 Medicines Recall: AOP Orphan Pharmaceuticals AG, Tetrabenazine 25 mg tablets, PL 21344/0015, (EL (20)A/13)

Read the official alert on GOV.UK — MedRegWatch re-presents it; GOV.UK is the authoritative source.

ClassClass 2
TypeMedicines recall/notification
Issued2 Mar 2020
ReferenceEL (20)A/13
CompanyAOP Orphan Pharmaceuticals AG
Product licencesPL 21344/0015

MDR Number

MDR 194-02/20

Company name

AOP Orphan Pharmaceuticals AG

Product description

Tetrabenazine 25 mg tablets PL 21344/0015

  • Batch Number: T1704UK
  • Expiry Date: 09/2020
  • Pack Size: 112
  • First Distributed: 31/12/2017

Advice for healthcare professionals

Stop supplying the above batch immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.

Company contacts for further information

For more information or medical information queries, please contact medinfo@aoporphan.com.

For stock control queries, please contact orderservice@aoporphan.com.

Recipients should bring it to the attention of relevant contacts by copy of this letter.

NHS Regional teams are asked to forward this to relevant clinics, general practitioners and community pharmacists.

Download document

Class 2 Medicines recall: AOP Orphan Pharmaceuticals AG, Tetrabenazine 25 mg tablets, PL 21344/0015, (EL (20)A/13)

Hold any of these licences?Check all your PL numbers against the full archive in one paste — or join the waitlist for automatic matching and an inspection-ready recall register.